Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-24

Clinical Trial Update: EnVision CF Multicenter Study of Glucose Tolerance in Cystic Fibrosis [NA]

View source ↗

Summary

Completed multicenter study evaluating glucose tolerance in individuals with cystic fibrosis-related diabetes (CFRD).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Katie Larson Ode | Conditions: Cystic Fibrosis-related Diabetes | NA | Status: COMPLETED